about
A common origin of the 4143insA ADAMTS13 mutation.Assessment of coeliac disease prevalence in patients with Down syndrome in Poland - a multi-centre study.[Suppression of immunological response in a newborn with congenital cytomegalovirus infection: diagnostic difficulties]Randomized clinical trial: pharmacokinetics and safety of multimatrix mesalamine for treatment of pediatric ulcerative colitis.Genetic architecture differences between pediatric and adult-onset inflammatory bowel diseases in the Polish population.Body composition as an indicator of the nutritional status in children with newly diagnosed ulcerative colitis and Crohn's disease - a prospective study.Comparative safety and efficacy of proton pump inhibitors in paediatric gastroesophageal reflux disease.Demographic characteristics of children with early clinical manifestation of inflammatory bowel disease.Solitary Rectal Ulcer Syndrome in Children: A Case Series Study.Endoscopic therapy of oesophageal strictures in children - a multicentre studyInduction and Maintenance Infliximab Therapy for the Treatment of Crohn's Disease with Perianal Fistulas in Children: Retrospective, Multicenter Study.Prediction of moderate and high grade vesicoureteral reflux after a first febrile urinary tract infection in children: construction and internal validation of a clinical decision rule.A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone.Evaluation of the infliximab therapy of severe form of pediatric Crohn's disease in Poland: Retrospective, multicenter studies.A Multicenter, Randomized, Observer-blinded, Active-controlled Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infection.[Drug poisonings in children hospitalized in The Regional Hospital No. 2 in Rzeszow in the years 2010-2014].Prucalopride is no more effective than placebo for children with functional constipation.[Two diagnostic assays for serum procalcitonin measurement in clinical practice].Induction and maintenance infliximab therapy in children with moderate to severe ulcerative colitis: Retrospective, multicenter study.Prophylaxis in children with haemophilia - the Polish experience.Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicenter case cohort study.Wolfram Syndrome. Case report.Procalcitonin and C-reactive protein in vaccination-associated adverse reactions.Assessment of induction therapy with infliximab in children with moderate to severe ulcerative colitis: a multi-center study.Bioelectrical Impedance Phase Angle as an Indicator of Malnutrition in Hospitalized Children with Diagnosed Inflammatory Bowel Diseases-A Case Control Study.Distinguishing between bacterial and aseptic meningitis in children: European comparison of two clinical decision rulesProcalcitonin to Reduce the Number of Unnecessary Cystographies in Children with a Urinary Tract Infection: A European Validation StudyPEG 3350 Versus Lactulose for Treatment of Functional Constipation in Children: Randomized StudyDual Delayed-Release Dexlansoprazole for Healing and Maintenance of Healed Erosive Esophagitis: A Safety Study in AdolescentsLB12. Safety and Efficacy of Fidaxomicin and Vancomycin in Pediatric Patients with Clostridium difficile Infection: Phase III, Multicenter, Investigator-blind, Randomized, Parallel Group (SUNSHINE) StudyThe Relationship between Body Composition and a Gluten Free Diet in Children with Celiac DiseaseDecreased Bioelectrical Impedance Phase Angle in Hospitalized Children and Adolescents with Newly Diagnosed Type 1 Diabetes: A Case-Control Study[Procalcitonin in diagnosis of purulent and aseptic meningitis in children][Concentration of procalcitonin and C-reactive protein in serum and erythrocyte sedimentation rate in active autoimmune diseases in children]Eosinophilic esophagitis in children: frequency, clinical manifestations, endoscopic findings, and seasonal distributionSerum procalcitonin concentration in children with liver diseaseCoexistent Takayasu arteritis and erythrokeratodermia variabilis: a case report[Thrombotic thrombocytopenic purpura in children -- pathophysiologic mechanisms and their clinical significance]Monotherapy with infliximab versus combination therapy in the maintenance of clinical remission in children with moderate to severe Crohn diseaseRedefining the Practical Utility of Blood Transcriptome Biomarkers in Inflammatory Bowel Diseases
P50
Q33371775-ED9E9EF0-CCD6-44C6-8FBC-1B72DBB74158Q33467772-F4CCCA1A-1416-4499-84D6-F8EA934C1509Q33498073-C1086A80-6A15-4FE7-B367-60658829B85EQ36557667-6375C637-7859-4B15-848B-65259168EF8BQ37529278-DD9C5CD9-65CC-4FB8-A2EF-D20003C3E106Q37714382-7ED9ED1E-BB6A-47AD-8169-06273EB3B00AQ38202595-44834364-1633-44D4-922D-F199BA8BE8F6Q38816412-564259FD-0184-45F2-8FFE-CE32C35AF452Q38931723-44834858-5B27-4484-886C-B48D7F43A9D0Q39314644-91432706-9A02-4529-B8D8-836ABD8FD7A5Q39389035-251F4A6C-6DBA-4415-84F3-51FC0459D404Q39685113-D50BACF9-EDC6-4718-B1F2-9C24E7058B3BQ39839810-BCA3A0C3-F13B-4441-BEB1-A66CE8F0B017Q40256725-E53A6619-5981-4F9C-8891-3E6A75A1A81AQ40680351-94893782-1A6D-47AF-96B0-D5DFBB168695Q40940378-EABFEA75-BCCA-476E-AAD2-2A7F263CD9F5Q43323400-CB85E95E-4F68-4655-99C5-1FECFDD51324Q43603447-8D12AB66-15BD-4B12-864F-2825CE5241F7Q44380350-7A218B2B-6C40-4952-B58B-D3AAAFE72290Q44840453-1F426561-1522-42FA-814A-F39E777215B1Q45013619-7A7D33B2-6251-4614-8914-4DFAB1ED9DF1Q47877039-43FDAE3A-B73D-47FF-9385-015F1079C249Q47967989-AB59FB26-9E88-49B6-9A8E-833DC7418DE8Q51017583-28A0FBB6-FBB1-4740-AB00-4C484291E12AQ55083801-E2616DD0-653C-4433-A9F2-68A0FAE52D94Q57792608-3A6DF067-824C-43DA-BD21-953902DFE136Q57792768-0852BF1F-8FDE-4DB4-BA7F-583C198AF647Q58089305-207E2AE4-AC2A-47B9-8AF6-E7D2182E9BDFQ58616073-5138BD17-B7B5-4D03-98E9-11A7580F2A6EQ59328063-C7A1CD0E-5162-4D2B-8C37-E539E977D748Q59789581-C52B4D35-71D8-4666-818F-AEFD74727DF2Q60919650-F16B5B7A-7869-4F18-867F-5CBAB759A4BCQ73503131-BB678AF9-A1B5-47F2-8EED-67AF603E369EQ79335248-6DB0A362-8E82-4CEC-A796-6CBCEC98B151Q82078559-AFD0794A-8589-4B6B-96FD-077AB9701550Q82702481-6520EBE5-EACF-4D08-AF44-A706D7EF3E89Q83193795-A31DEF77-02DD-48FA-A875-7B6174DF8F3BQ83868566-2CBE5487-F251-47BD-830D-4AEAD5A298E1Q86486752-EA07DC91-ED14-4CAB-B21F-6C4BA3884C6FQ90429195-3288D388-CA0C-4688-A265-1B9D9756CDF0
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-1626-1283
@en
name
Bartosz Korczowski
@ast
Bartosz Korczowski
@ca
Bartosz Korczowski
@cs
Bartosz Korczowski
@en
Bartosz Korczowski
@es
Bartosz Korczowski
@gl
Bartosz Korczowski
@hr
Bartosz Korczowski
@hsb
Bartosz Korczowski
@it
Bartosz Korczowski
@nl
type
label
Bartosz Korczowski
@ast
Bartosz Korczowski
@ca
Bartosz Korczowski
@cs
Bartosz Korczowski
@en
Bartosz Korczowski
@es
Bartosz Korczowski
@gl
Bartosz Korczowski
@hr
Bartosz Korczowski
@hsb
Bartosz Korczowski
@it
Bartosz Korczowski
@nl
prefLabel
Bartosz Korczowski
@ast
Bartosz Korczowski
@ca
Bartosz Korczowski
@cs
Bartosz Korczowski
@en
Bartosz Korczowski
@es
Bartosz Korczowski
@gl
Bartosz Korczowski
@hr
Bartosz Korczowski
@hsb
Bartosz Korczowski
@it
Bartosz Korczowski
@nl
P214
P106
P1153
55932962900
P1412
P1559
Bartosz Korczowski
@pl
P21
P214
P27
P31
P3124
P496
0000-0003-1626-1283
P734
P735
P7859
viaf-161083852